Galanin Receptor 1 Antikörper (Middle Region)
Kurzübersicht für Galanin Receptor 1 Antikörper (Middle Region) (ABIN952452)
Target
Alle Galanin Receptor 1 (GALR1) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 180-209, Middle Region
-
Spezifität
- This antibody recognizes Human GALR1 (Center).
-
Aufreinigung
- Protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 180~209 amino acids from the Center region of Human GALR1
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- Galanin Receptor 1 (GALR1)
-
Andere Bezeichnung
- GALR1
-
Hintergrund
- GALR1 elicits a range of biological effects by interaction with specific G-protein-coupled receptors. Galanin receptors are seven-transmembrane proteins shown to activate a variety of intracellular second-messenger pathways. GALR1 inhibits adenylyl cyclase via a G protein of the Gi/Go family. GALR1 is widely expressed in the brain and spinal cord, as well as in peripheral sites such as the small intestine and heart.Synonyms: GAL1-R, GALNR, GALNR1, GALR-1, Galanin receptor type 1
-
Molekulargewicht
- 38980 Da
-
Gen-ID
- 2587
-
NCBI Accession
- NP_001471
-
Pathways
- cAMP Metabolic Process
Target
-